Metformin as a Fetal Hemoglobin Inducer in Non-transfusion Dependent Thalassemia Patients
Conclusion: Metformin intake, in addition to hydroxyurea, did not yield any extra benefit among patients with NTDT.
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
More News: Bilirubin | Blood Transusion | Fortamet | Hematology | India Health | Laboratory Medicine | Liver | Metformin | Statistics | Study | Sugar | Urology & Nephrology